Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
Open accessThe DOI matches its Crossref record; 122 of the 125 references it cites were found in a registry or an index.
Abstract
Cancer tissues are composed of cancer cells and the surrounding stromal cells (e.g., fibroblasts, vascular endothelial cells, and immune cells), in addition to the extracellular matrix. Most studies investigating carcinogenesis and the progression, invasion, metastasis, and angiogenesis of cancer have focused on alterations in cancer cells, including genetic and epigenetic changes. Recently, interactions between cancer cells and the stroma have attracted considerable attention, and increasing evidence has accumulated on this. Several researchers have gradually clarified the origins, features, and roles of cancer-associated fibroblasts (CAFs), a major component of the cancer stroma. CAFs function in a similar manner to myofibroblasts during wound healing. We previously reported the relationship between CAFs and angiogenesis. Interleukin-6 (IL-6), a multifunctional cytokine, plays a central role in regulating inflammatory and immune responses, and important roles in the progression, including proliferation, migration, and angiogenesis, of several cancers. We showed that CAFs are an important IL-6 source and that anti-IL-6 receptor antibody suppressed angiogenesis and inhibited tumor-stroma interactions. Furthermore, CAFs contribute to drug-resistance acquisition in cancer cells. The interaction between cancer cells and the stroma could be a potential target for anti-cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, recent studies indicated that CAFs consist of several types of stromal cells that differ in their origin, functions, number, and phenotype [21, 22, 23, 24].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer
Sun, X., Mao, Y., Wang, J., Zu, L., Hao, M., Cheng, G., Qu, Q., Cui, D., Keller, E. T., Chen, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.158 · Cited by 75
RetractedSun, X., Mao, Y., Wang, J., Zu, L., Hao, M., Cheng, G., Qu, Q., Cui, D., Keller, E. T., CHEN, X., et al. (2014) · Oncogene · doi:10.1038/onc.2014.224 · Cited by 40
RetractedChen, L., Qu, C., Chen, H., Xu, L., Qi, Q., Luo, J., Wang, K., Meng, Z., Chen, Z., Wang, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096177 · Cited by 30
RetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“This phenomenon is known as “Warburg effect” [84].”
BackgroundThe distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“proposed the theory that a “tumor is a wound that never heals” [2].”
BackgroundThe Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290 · cited 2×
“These myofibroblasts acquire de novo expressed α-SMA, contractile stress fibers, and the ED-A splice variant of fibronectin [5,7].”
BackgroundComplex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Cited by
Items 401–500 of 814
Galván, J. A., Wiprächtiger, J., Slotta‐Huspenina, J., Feith, M., Ott, K., Kröll, D., Seiler, C. A., & Langer, R. (2019) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02714-6 · Cited by 23
Targeting Glioblastoma Tumor Microenvironment
Butler, M., Prasad, S., & Srivastava, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59038-3_1 · Cited by 22
Alhussan, A., Palmerley, N., Smazynski, J., Karasinska, J. M., Renouf, D. J., Schaeffer, D. F., Beckham, W., Alexander, A., & Chithrani, D. B. (2022) · Cancers · doi:10.3390/cancers14153586 · Cited by 21
Heterogeneity of the Tumor Microenvironment Across Molecular Subtypes of Breast Cancer
Kashyap, D., Bal, A., Irinike, S., Khare, S., Bhattacharya, S., Das, A., & Singh, G. (2023) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000001139 · Cited by 24
Immune Escape Mechanism of Cancer
Caner, A. (2023) · Current Molecular Biology Reports · doi:10.1007/s40610-023-00157-2 · Cited by 24
Yuan, K., Feng, Y., Wang, H., Zhao, L., Wang, W. T., Wang, T., Feng, Y., Huang, G., & Xu, A. (2020) · PeerJ · doi:10.7717/peerj.8654 · Cited by 22
A Novel Orthotopic Liver Cancer Model for Creating a Human-like Tumor Microenvironment
Qiu, R., Murata, S., Cheng, C., Mori, A., Nie, Y., Mikami, S., Hasegawa, S., Tadokoro, T., Okamoto, S., & Taniguchi, H. (2021) · Cancers · doi:10.3390/cancers13163997 · Cited by 23
Yamato, H., Kimura, K., Fukui, E., Kanou, T., Ose, N., Funaki, S., Minami, M., & Shintani, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-00717-5 · Cited by 24
[Retracted] Fibroblasts in Scar Formation: Biology and Clinical Translation
Qian, H., Shan, Y., Gong, R., Lin, D., Zhang, M., Wang, C., & Wang, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4586569 · Cited by 20
RetractedHelicobacter pylori–activated fibroblasts as a silent partner in gastric cancer development
Krzysiek-Mączka, G., Brzozowski, T., & Ptak‐Belowska, A. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10122-1 · Cited by 20
Xiao, J., Song, Y., Gao, R., You, M., Deng, C., Tan, G., & Li, W. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04650-1 · Cited by 20
Role of Microenvironmental Components in Head and Neck Squamous Cell Carcinoma
Jumaniyazova, E. D., Lokhonina, А. V., Dzhalilova, D. S., Kosyreva, A. M., & Fatkhudinov, T. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111616 · Cited by 22
Kawamura, T., Yamamoto, M., Suzuki, K., Suzuki, Y., Kamishima, M., Sakata, M., Kurachi, K., Setoh, M., Konno, H., & Takeuchi, H. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy368 · Cited by 20
Nii, T., Makino, K., & Tabata, Y. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2020.02.003 · Cited by 22
Jena, B. C., Rout, L., Dey, A., & Mandal, M. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30419 · Cited by 20
Epigenetic alterations at distal enhancers are linked to proliferation in human breast cancer
Ankill, J., Aure, M. R. R., Bjørklund, S. S., Langberg, S. R. E., Bathen, T. F., Borgen, E., Engebråten, O., Fritzman, B., Garred, Ø., Geisler, J., et al. (2022) · NAR Cancer · doi:10.1093/narcan/zcac008 · Cited by 20
Likonen, D., Pinchasi, M., Beery, E., Sarsor, Z., Signorini, L. F., Gervits, A., Sharan, R., Lahav, M., Raanani, P., & Uziel, O. (2022) · Scientific Reports · doi:10.1038/s41598-022-20186-8 · Cited by 20
Cheng, Q., Zuo, X., Wang, Z., Lu, W., Jiang, Y., Liu, J., Li, X., Xu, Q., Zhu, S., Liu, X., et al. (2025) · Respiratory Research · doi:10.1186/s12931-025-03263-0 · Cited by 22
Li, W., Liu, Z., Cen, X., Xu, J., Zhao, S., Wang, B., Zhang, W., & Qiu, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1019072 · Cited by 20
Villéger, R., Chulkina, M., Mifflin, R. C., Markov, N. S., Trieu, J. A., Sinha, M., Johnson, P. R., Saada, J. I., Adegboyega, P. A., Luxon, B. A., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02066-0 · Cited by 21
Photon- and Proton-Mediated Biological Effects: What Has Been Learned?
Jumaniyazova, E. D., Смык, Д., Vishnyakova, P., Fatkhudinov, T., & Gordon, K. B. (2022) · Life · doi:10.3390/life13010030 · Cited by 19
Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells
Ji, X., Zhu, X., & Lu, X. (2017) · Future Oncology · doi:10.2217/fon-2017-0054 · Cited by 19
The focal adhesion scaffold protein Hic-5 regulates vimentin organization in fibroblasts
Vohnoutka, R. B., Gulvady, A. C., Goreczny, G. J., Alpha, K. M., Handelman, S. K., Sexton, J. Z., & Turner, C. E. (2019) · Molecular Biology of the Cell · doi:10.1091/mbc.e19-08-0442 · Cited by 19
Salah, R. A., Nasr, M., El-Derby, A. M., Elkodous, M. A., Mohamed, R. H., El-Ekiaby, N. M., Osama, A., Elshenawy, S. E., Hamad, M. H. M., Magdeldin, S., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120168 · Cited by 19
Both cancerous miR‐21 and stromal miR‐21 in urothelial carcinoma are related to tumour progression
Ohno, R., Uozaki, H., Kikuchi, Y., Kumagai, A., Aso, T., Watanabe, M., Watabe, S., Muto, S., & Yamaguchi, R. (2016) · Histopathology · doi:10.1111/his.13032 · Cited by 19
Fascin is involved in cancer cell invasion and is regulated by stromal factors
Zhang, X., Cho, I., Park, J. Y., Lee, M. W., & Hwang, Y. S. (2018) · Oncology Reports · doi:10.3892/or.2018.6847 · Cited by 22
Shukla, P., Bera, A. K., Ghosh, A. K., Kiranmai, G., & Pati, F. (2024) · Biofabrication · doi:10.1088/1758-5090/ad586b · Cited by 18
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies
Dendl, K., Koerber, S. A., Tamburini, K., Mori, Y., Cardinale, J., Haberkorn, U., & Giesel, F. L. (2022) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2022.04.002 · Cited by 18
Yu, X., Liu, R., Song, L., Gao, W., Wang, X., & Zhang, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1165732 · Cited by 22
Is There a Role for FAPI PET in Urological Cancers?
Ortolan, N., Urso, L., Zamberlan, I., Filippi, L., Buffi, N. M., Cittanti, C., Uccelli, L., Bartolomei, M., & Evangelista, L. (2024) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-024-00735-9 · Cited by 18
Wang, Q., Zhang, Y., Zhu, L., Pan, L., Yu, M., Shen, W., Li, B., Zhang, W., & Liu, L. (2019) · Cancer Science · doi:10.1111/cas.13991 · Cited by 19
Vivacqua, A., Muoio, M. G., Miglietta, A., & Maggiolini, M. (2019) · Cancers · doi:10.3390/cancers11030412 · Cited by 18
Challapalli, R. S., Dwyer, R. M., McInerney, N. M., Kerin, M. J., & Lowery, A. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10038-1 · Cited by 20
Davis, A. M., Rapley, A., Dawson, W. O., Young, L. S., & Morris, M. A. (2021) · Pathogens · doi:10.3390/pathogens10080982 · Cited by 18
Luque, M., Sanz-Álvarez, M., Santamaría, A., Zazo, S., Cristóbal, I., de la Fuente, L., Mínguez, P., Eroles, P., Rovira, A., Albanell, J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413297 · Cited by 20
Aliya, S., Farani, M. R., Kim, E., Kim, S., Gupta, V. K., Kumar, K., & Huh, Y. S. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115862 · Cited by 18
Isolation of Fibroblast-Activation Protein-Specific Cancer-Associated Fibroblasts
Huang, Y., Zhou, S., Huang, Y., Zheng, D., Mao, Q., He, J., Wang, Y., Xue, D., Lü, X., Yang, N., et al. (2017) · BioMed Research International · doi:10.1155/2017/4825108 · Cited by 19
Signaling roadmap to epithelial–mesenchymal transition in pterygium, TWIST1 centralized
Meshkani, S. E., Kooshan, N., moghadam, A. B., Falanji, F., Adli, A., Baghbani‐Arani, F., Arian, A. G., & Rad, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28447 · Cited by 18
Romano, V., Ruocco, M. R., Carotenuto, P., Barbato, A., Venuta, A., Acampora, V., Lella, S. D., Vigliar, E., Iaccarino, A., Troncone, G., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126875 · Cited by 20
Famta, P., Shah, S., Dey, B., Kumar, K. C., Bagasariya, D., Vambhurkar, G. B., Pandey, G., Sharma, A., Srinivasarao, D. A., Kumar, R., et al. (2024) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.01.001 · Cited by 21
Yoshino, F., Amano, T., Zou, Y., Xu, J., Kimura, F., Furusho, Y., Chano, T., Murakami, T., Zhao, L., & Komatsu, N. (2020) · Small · doi:10.1002/smll.202003468 · Cited by 17
The Role of Stroma in Ovarian Cancer
Silva, A. C. D., Jammal, M. P., Crispim, P. C. A., Murta, E. F. C., & Nomelini, R. S. (2019) · Immunological Investigations · doi:10.1080/08820139.2019.1658770 · Cited by 17
Guo, L., Shi, D., Meng, D., Shang, M., Sun, X. Y., Zhou, X., Liu, X., Zhao, Y., & Li, J. (2019) · Nanomedicine · doi:10.2217/nnm-2019-0302 · Cited by 17
Chu, L., Wang, F., Zhang, W., Li, H., Xu, J., & Tong, X. (2020) · Technology in Cancer Research & Treatment · doi:10.1177/1533033820977535 · Cited by 17
Alhussan, A., Bromma, K., Bozdoğan, E. P. D., Metcalfe, A. L., Karasinska, J. M., Beckham, W., Alexander, A., Renouf, D. J., Schaeffer, D. F., & Chithrani, D. B. (2021) · Current Oncology · doi:10.3390/curroncol28030183 · Cited by 19
Radiation-assisted strategies provide new perspectives to improve the nanoparticle delivery to tumor
Zhang, D., He, J., & Zhou, M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114642 · Cited by 18
Ueno, A., Masugi, Y., Yamazaki, K., Kurebayashi, Y., Tsujikawa, H., Effendi, K., Ojima, H., & Sakamoto, M. (2020) · Pathology International · doi:10.1111/pin.12895 · Cited by 18
Updates on mechanistic insights and targeting of tumour metastasis
Feng, Z., Yu, Q., Zhang, T., Tie, W., Li, J., & Zhou, X. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14931 · Cited by 17
Huang, B., Zheng, S., Sudarshan, K., Mukkamala, R., Srinivasarao, M., Sardesai, T., Yang, X., Chu, H., & Low, P. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1539265 · Cited by 20
Chen, Y., Jung, S., Zhang, Z., Wicha, M. S., & Yoon, E. (2019) · Integrative Biology · doi:10.1093/intbio/zyz029 · Cited by 16
Liu, Y., Liu, Y., Zheng, X. S., Zhao, L., & Zhang, X. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901713 · Cited by 16
Microenvironmental modulation of the developing tumour: an immune‐stromal dialogue
Jones, J. O., Moody, W. M., & Shields, J. D. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12773 · Cited by 18
Deo, A., Thorat, R. A., Dhadve, A., De, A., Rekhi, B., & Ray, P. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166282 · Cited by 16
Gardiner, J. C., & Cukierman, E. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2022.01.004 · Cited by 16
Drug Metabolism for the Identification of Clinical Biomarkers in Breast Cancer
Costa, B., & Vale, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063181 · Cited by 22
Nakai, N., Hara, M., Takahashi, H., Shiga, K., Hirokawa, T., Maeda, Y., Yanagita, T., Ando, N., Takasu, K., Suzuki, T., et al. (2022) · Oncology Reports · doi:10.3892/or.2022.8323 · Cited by 17
Self-citationLi, L., Zhou, Y., Zhang, Y., Hu, H., Mao, H., & Selaru, F. M. (2023) · iScience · doi:10.1016/j.isci.2023.106095 · Cited by 16
CaMKII Mediates TGFβ1-Induced Fibroblasts Activation and Its Cross Talk with Colon Cancer Cells
Chen, W., Chen, Y., Su, J., Kang, J., Ding, Y., Ai, W., Zhang, J., Luo, H., & An, P. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06847-0 · Cited by 16
The Role of Epithelial-to-Mesenchymal Transition in Cutaneous Squamous Cell Carcinoma
Fernández‐Figueras, M. T., & Puig, L. (2020) · Current Treatment Options in Oncology · doi:10.1007/s11864-020-00735-x · Cited by 16
Geng, S., Xiang, T., Shi, Y., Cao, M., Wang, D., Wang, J., Li, X., Song, H., Zhang, Z., Shi, J., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.01.002 · Cited by 15
Negrete-García, M. C., Ramírez-Rodriguez, S. L., Rangel‐Escareño, C., Muñoz-Montero, S. A., Kelly-García, J., Vázquez-Manríquez, M. E., Santillán, P., Montaño, M., Ramírez-Martínez, G., Ramírez‐Venegas, A., et al. (2018) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.246.107 · Cited by 15
The role of the microenvironment in tumor growth and spreading
Bitsadze, V. O., Викторовна, С. Е., Солопова, А. Г., Khizroeva, J. K., Yakubova, F. E., Orudzhova, Е. А., Degtyareva, N. D., Егорова, Е., Makatsariya, N. А., Samburova, N. V., et al. (2024) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2024.489 · Cited by 15
Chen, Y., Xue, Y., Yan, C., Jin, J., Liu, Y., Li, J., Han, S., & Liu, J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404642 · Cited by 17
Zuo, T., Zhang, J., Yang, J., Xu, R. F., Hu, Z., Wang, Z., Deng, H., & Shen, Q. (2021) · Biomaterials Science · doi:10.1039/d0bm01878c · Cited by 15
Ham, J., Wang, B., Po, J. W., Singh, A., Niles, N., & Lee, C. S. (2021) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-207357 · Cited by 17
The role of exosome heterogeneity in epithelial ovarian cancer
Lee, A. H., Koh, I. L., & Dawson, M. (2022) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2022.100040 · Cited by 15
Hurtado, P., Martínez-Peña, I., Yepes-Rodríguez, S., Bascoy-Otero, M., Abuín, C., Fernández-Santiago, C., Sanchez, L. E., López‐López, R., & Piñeiro, R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1076432 · Cited by 18
Suvarna, K., Honda, K., Muroi, M., Kondoh, Y., Osada, H., & Watanabe, N. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004741 · Cited by 15
Inoue, C., Tamatsuki, D., Miki, Y., Saito, R., Okada, Y., & Sasano, H. (2019) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02587-9 · Cited by 17
Breast Mammographic Density: Stromal Implications on Breast Cancer Detection and Therapy
Fernández‐Nogueira, P., Mancino, M., Fuster, G., Bragado, P., de Puig, M. P., Gascón, P., Casado, F. J., & Carbó, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030776 · Cited by 15
Extracellular Vesicles in the Tumor Microenvironment: Various Implications in Tumor Progression
Boomgarden, A. C., Sheehan, C. S., & D’Souza‐Schorey, C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43093-1_9 · Cited by 15
Stromal regulation of tumor-associated lymphatics
Munir, H., Mazzaglia, C., & Shields, J. D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.08.001 · Cited by 15
Wang, J., Wang, Y., & Jiang, X. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2384071 · Cited by 14
Miyamura, T., Sakamoto, N., Ishida, K., Kakugawa, T., Taniguchi, H., Akiyama, Y., Okuno, D., Hara, A., Kido, T., Ishimoto, H., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01490-1 · Cited by 14
Discoidin Domain Receptor 2 Expression as Worse Prognostic Marker in Invasive Breast Cancer
Romayor, I., García‐Vaquero, M. L., Márquez, J., Arteta, B., Barceló, R., & Benedicto, A. (2022) · The Breast Journal · doi:10.1155/2022/5169405 · Cited by 14
Kitamura, Y., Koma, Y., Tanigawa, K., Tsukamoto, S., Azumi, Y., Miyako, S., Urakami, S., Kodama, T., Nishio, M., Shigeoka, M., et al. (2023) · Cancers · doi:10.3390/cancers15020394 · Cited by 14
Xin, X., & Yang, S. (2019) · Biochemical Engineering Journal · doi:10.1016/j.bej.2019.05.007 · Cited by 14
Krämer, M., Plum, P. S., Camacho, O. V., Folz‐Donahue, K., Thelen, M., Garcia‐Marquez, I., Wölwer, C. B., Büsker, S., Wittig, J., Franitza, M., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12680 · Cited by 14
Hatlen, R. R., & Rajagopalan, P. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.11.044 · Cited by 14
Chang, K., Chen, S., Sung, H., Hsu, S.-Y., Lin, W.-Y., Hou, C., Lin, Y., Feng, T., Tsui, K.-H., & Juang, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911437 · Cited by 13
Yu, X., Yan, S.-S., Liu, R.-J., & Zhang, Y. (2024) · International Urology and Nephrology · doi:10.1007/s11255-024-04012-w · Cited by 13
Quantitative proteomics analysis of triple-negative breast cancers
Mariano, N. C., Marotti, J. D., Chen, Y., Karakyriakou, B., Salgado, R., Christensen, B. C., Miller, T. W., & Kettenbach, A. N. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00907-8 · Cited by 15
The cellular and molecular mediators of metastasis to the lung
Cucanic, O., Farnsworth, R. H., & Stacker, S. A. (2022) · Growth Factors · doi:10.1080/08977194.2022.2087520 · Cited by 14
Pu, Q., & Gao, H. (2023) · Cancers · doi:10.3390/cancers15225493 · Cited by 14
HBV infection effects prognosis and activates the immune response in intrahepatic cholangiocarcinoma
Li, Z., Gao, Q., Wu, Y., Ma, X., Wu, F., Luan, S., Chen, S., Shao, S., Shen, Y., Zhang, D., et al. (2024) · Hepatology Communications · doi:10.1097/hc9.0000000000000360 · Cited by 13
Exosomes in tumor‐stroma crosstalk: Shaping the immune microenvironment in colorectal cancer
Zhang, Y., Huo, M., Li, W., Zhang, H., Liu, Q., Jiang, J., Fu, Y., & Huang, C. (2024) · The FASEB Journal · doi:10.1096/fj.202302297r · Cited by 16
Identification of Novel Single-Domain Antibodies against FGF7 Using Phage Display Technology
Jafari, B., Hamzeh‐Mivehroud, M., Moosavi‐Movahedi, A. A., & Dastmalchi, S. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217728520 · Cited by 13
Ji, X., Shen, Z., Zhao, B., Yuan, X., & Zhu, X. (2018) · Medicine · doi:10.1097/md.0000000000010101 · Cited by 13
Liang, H., Chu, X., Zhao, J., Xing, G., & Si, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.8424 · Cited by 14
Kong, J., Zhao, H., Shang, Q., Ma, Z., Kang, N., Tan, J., Al-Raimi, H. A. I., & Liu, T. (2018) · Cell Communication & Adhesion · doi:10.1080/15419061.2018.1464000 · Cited by 13
A Review on the Recent Advancement in “Tumour Spheroids-on-a-Chip”
Khot, M. I., Levenstein, M. A., Kapur, N., & Jayne, D. G. (2019) · Journal of Cancer Research and Practice · doi:10.4103/jcrp.jcrp_23_18 · Cited by 13
Enhancing CAR T cell efficacy: the next step toward a clinical revolution?
Namuduri, M., & Brentjens, R. J. (2020) · Expert Review of Hematology · doi:10.1080/17474086.2020.1753501 · Cited by 14
Mesenchymal stem cells in cancer therapy; the art of harnessing a foe to a friend.
Karimi‐Shahri, M., Javid, H., Mashhad, A. S., Yazdani, S., & Hashemy, S. I. (2021) · PubMed Central · doi:10.22038/ijbms.2021.58227.12934 · Cited by 18
Ruan, J.-L., Hsu, J., Browning, R. J., Stride, E., Yildiz, Y. O., Vojnovic, B., & Kiltie, A. E. (2018) · European Urology Oncology · doi:10.1016/j.euo.2018.08.014 · Cited by 13
Initial Clinical Experience using 68Ga-FAPI-46 PET/CT for Detecting Various Cancer TypesPreprint
Dadgar, H., Norouzbeigi, N., Assadi, M., Albalooshi, B., Al‐Ibraheem, A., Haidar, M., Omar, Y., Esmail, A. A. H., Al-Alawi, H. M., Usmani, S., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3395633/v1 · Cited by 13
Dawalibi, A., Bakir, M. A., & Mohammad, K. S. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2025.28 · Cited by 12
Ba, P., Zhang, X., Yu, M., Li, L., Duan, X., Wang, M., Lv, S., Fu, G., Yang, P., Yang, C., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.10556 · Cited by 14
Yu, X., Lin, W., Spirtos, A. N., Wang, Y., Chen, H., Ye, J., Parker, J. E., Liu, C. C., Wang, Y., Quinn, G. M., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02489-9 · Cited by 12
Wang, Y., Liang, H., & Zheng, J. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.154159 · Cited by 12
Chopra, S., Mathur, Y., Roesch, F., Moon, E. S., Rana, N., Irrinki, S., Walia, R., Duseja, A. K., Singh, H., Kumar, R., et al. (2024) · Academic Radiology · doi:10.1016/j.acra.2023.12.002 · Cited by 12
Metadata
- Authors
- Shiga, K., Hara, M., Nagasaki, T., Sato, T., Takahashi, H., & Takeyama, H.
- Affiliations
- Nagoya City University (JP)
- Corresponding author
- Hara, Masayasu
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2015-12-11
- Volume
- 7
- Issue
- 4
- Pages
- 2443-2458
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC4695902
- OpenAlex
- W2190528488
- Cited by
- 774
- References
- 125
- Citations by year
- 2026: 29 · 2025: 42 · 2024: 61 · 2023: 71 · 2022: 83 · 2021: 103 · 2020: 121 · 2019: 104 · 2018: 87 · 2017: 49 · 2016: 21
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- cancer-associated fibroblasts, tumor microenvironment, tumor stroma, tumor-stroma interactions, angiogenesis, interleukin-6, IL-6 receptor, myofibroblasts, drug resistance, tumor progression, cancer therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.